Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Epinephrine Hydrochloride Injection
- Product Name
- 盐酸肾上腺素注射液
- Approval Number
- 国药准字H20254200
- Approval Date
- May 20, 2025
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20244190
- Approval Date
- Oct 15, 2024
NMPA
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20234738
- Approval Date
- Dec 29, 2023
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20223942
- Approval Date
- Dec 30, 2022
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20223943
- Approval Date
- Dec 30, 2022
NMPA
Clinical Trials
No trials found
News
No news found